Familial dysautonomia (Riley-Day syndrome) in Children

Introduction to Familial Dysautonomia (Riley-Day Syndrome)

Familial Dysautonomia (FD), also known as Riley-Day syndrome or hereditary sensory and autonomic neuropathy type III (HSAN-III), is a rare genetic disorder primarily affecting the development and function of the autonomic nervous system. It is characterized by widespread sensory and autonomic dysfunction, leading to a variety of clinical manifestations that significantly impact quality of life.

Key points:

  • Autosomal recessive inheritance pattern
  • Predominantly affects individuals of Ashkenazi Jewish descent
  • Incidence: approximately 1 in 3,700 live births in the Ashkenazi Jewish population
  • Symptoms typically present in early infancy
  • Multisystem disorder affecting various organs and functions

Etiology of Familial Dysautonomia

Familial Dysautonomia is caused by mutations in the IKBKAP gene (Inhibitor of Kappa B Kinase Complex-Associated Protein), located on chromosome 9q31. This gene provides instructions for producing the IKAP protein, which is crucial for the development and maintenance of neurons in the autonomic and sensory nervous systems.

Genetic aspects:

  • Autosomal recessive inheritance
  • Most common mutation: IVS20+6T→C splice mutation (accounts for >99% of FD cases)
  • Rare cases involve other mutations in the IKBKAP gene
  • Mutation leads to tissue-specific reduction of IKAP protein, particularly in the nervous system

Pathophysiology:

  • Reduced IKAP protein leads to impaired development and function of autonomic and sensory neurons
  • Progressive degeneration of small unmyelinated fibers and large myelinated fibers
  • Decreased number of unmyelinated axons in peripheral nerves
  • Reduced number of fungiform papillae on the tongue
  • Impaired development of the dorsal root ganglia and sympathetic chain ganglia

Clinical Presentation of Familial Dysautonomia

Familial Dysautonomia presents with a wide array of symptoms affecting multiple organ systems. The clinical manifestations can vary in severity and typically appear in early infancy.

Neurological Manifestations:

  • Impaired pain and temperature perception
  • Absence of deep tendon reflexes
  • Impaired corneal reflex
  • Ataxia and unsteady gait
  • Dysarthria
  • Intellectual disability (in some cases)

Autonomic Dysfunction:

  • Orthostatic hypotension
  • Episodic hypertension during autonomic crises
  • Impaired thermoregulation
  • Excessive sweating
  • Skin blotching

Gastrointestinal Issues:

  • Dysphagia
  • Gastroesophageal reflux
  • Recurrent vomiting
  • Poor feeding in infancy
  • Constipation or diarrhea

Respiratory Problems:

  • Recurrent aspiration pneumonia
  • Sleep apnea
  • Decreased cough reflex

Ophthalmological Issues:

  • Alacrima (absence of tears)
  • Corneal ulceration
  • Optic nerve atrophy

Other Features:

  • Characteristic facies: smooth tongue with absent fungiform papillae, narrow nasal bridge
  • Short stature
  • Scoliosis
  • Delayed puberty
  • Chronic kidney disease

Diagnosis of Familial Dysautonomia

Diagnosis of Familial Dysautonomia is based on clinical presentation, family history, and genetic testing. Early diagnosis is crucial for appropriate management and genetic counseling.

Clinical Diagnosis:

  • Characteristic clinical features (as described in Clinical Presentation)
  • Family history consistent with autosomal recessive inheritance
  • Ashkenazi Jewish ancestry

Genetic Testing:

  • Molecular genetic testing for IKBKAP gene mutations
  • Targeted analysis for the common IVS20+6T→C mutation
  • Sequence analysis of the entire IKBKAP gene if targeted analysis is negative

Supportive Diagnostic Tests:

  • Absence of fungiform papillae on tongue examination
  • Decreased or absent deep tendon reflexes
  • Abnormal pupillary response to methacholine
  • Abnormal histamine test (reduced axon flare response)
  • Decreased or absent tears with corneal stimulation

Differential Diagnosis:

  • Other hereditary sensory and autonomic neuropathies (HSAN types I, II, IV, V)
  • Congenital insensitivity to pain with anhidrosis (CIPA)
  • Autonomic dysfunction in other neurological disorders (e.g., Parkinson's disease, multiple system atrophy)
  • Mitochondrial disorders

Management of Familial Dysautonomia

Management of Familial Dysautonomia is multidisciplinary and focuses on symptomatic treatment, prevention of complications, and supportive care. There is no cure for the condition, and treatment is lifelong.

Neurological Management:

  • Physical therapy to improve balance and coordination
  • Occupational therapy for activities of daily living
  • Speech therapy for dysarthria and swallowing difficulties
  • Medications for neuropathic pain if present (e.g., gabapentin, pregabalin)

Autonomic Dysfunction Management:

  • Fludrocortisone or midodrine for orthostatic hypotension
  • Clonidine or labetalol for hypertensive crises
  • Proper hydration and salt intake
  • Compression stockings
  • Environmental temperature control

Gastrointestinal Management:

  • Gastrostomy tube placement for severe feeding difficulties
  • Proton pump inhibitors for gastroesophageal reflux
  • Dietary modifications (thickened liquids, soft foods)
  • Stool softeners or laxatives for constipation

Respiratory Care:

  • Chest physiotherapy
  • Pneumococcal and influenza vaccinations
  • Prompt treatment of respiratory infections
  • CPAP or BiPAP for sleep apnea

Ophthalmological Care:

  • Artificial tears and lubricating eye drops
  • Regular ophthalmological check-ups
  • Protective eyewear

Other Interventions:

  • Growth hormone therapy for short stature
  • Scoliosis management (bracing or surgery)
  • Renal function monitoring
  • Psychological support for patients and families

Experimental Therapies:

  • Tocotrienols (Vitamin E analogs) to increase IKAP protein levels
  • Kinetin to improve splicing of the mutant IKBKAP gene
  • Gene therapy approaches (in research phase)

Prognosis of Familial Dysautonomia

The prognosis for individuals with Familial Dysautonomia has improved significantly with advances in supportive care and early diagnosis. However, it remains a life-limiting condition with significant morbidity.

Life Expectancy:

  • Historical data: 50% survival to 20 years of age
  • Current data: >50% survival to 40 years of age
  • Improved survival due to better management of autonomic crises and respiratory complications

Quality of Life:

  • Varies widely depending on disease severity and management
  • Many patients able to attend school and engage in social activities
  • Some adults able to live semi-independently

Major Causes of Morbidity and Mortality:

  • Respiratory complications (aspiration pneumonia, respiratory failure)
  • Renal failure
  • Autonomic crises
  • Sepsis

Long-term Complications:

  • Progressive kyphoscoliosis
  • Chronic lung disease
  • Visual impairment
  • Chronic kidney disease
  • Cardiovascular complications

Factors Influencing Prognosis:

  • Early diagnosis and intervention
  • Adherence to treatment regimens
  • Quality of supportive care
  • Management of autonomic crises
  • Prevention and prompt treatment of infections


Familial Dysautonomia (Riley-Day Syndrome) in Children
  1. What is Familial Dysautonomia?
    Familial Dysautonomia is a genetic disorder affecting the development and function of neurons in the autonomic nervous system.
  2. What is the genetic cause of Familial Dysautonomia?
    Familial Dysautonomia is caused by mutations in the IKBKAP gene, inherited in an autosomal recessive pattern.
  3. What are the main symptoms of Familial Dysautonomia in children?
    Main symptoms include decreased pain and temperature sensitivity, unstable blood pressure, poor growth, and recurrent pneumonia.
  4. How is Familial Dysautonomia diagnosed in children?
    Diagnosis is based on clinical symptoms, genetic testing for IKBKAP mutations, and sometimes autonomic function tests.
  5. What populations are most commonly affected by Familial Dysautonomia?
    Familial Dysautonomia primarily affects individuals of Ashkenazi Jewish descent.
  6. How does Familial Dysautonomia affect a child's ability to feel pain?
    Children with Familial Dysautonomia have decreased sensitivity to pain, which can lead to unnoticed injuries.
  7. What gastrointestinal issues are common in children with Familial Dysautonomia?
    Common GI issues include poor coordination of swallowing, gastroesophageal reflux, and cyclic vomiting.
  8. How does Familial Dysautonomia affect a child's growth and development?
    Familial Dysautonomia often leads to poor growth, delayed development, and learning difficulties.
  9. What respiratory issues are common in children with Familial Dysautonomia?
    Recurrent aspiration pneumonia and decreased lung function are common due to poor coordination of swallowing and breathing.
  10. How does Familial Dysautonomia affect a child's temperature regulation?
    Children with Familial Dysautonomia often have difficulty regulating body temperature, leading to episodes of hyperthermia or hypothermia.
  11. What is the long-term prognosis for children with Familial Dysautonomia?
    While life expectancy has improved with better management, individuals with Familial Dysautonomia often have reduced lifespan and various chronic health issues.
  12. How does Familial Dysautonomia affect a child's cardiovascular system?
    It can cause blood pressure instability, with episodes of severe hypertension or hypotension, and irregular heart rhythms.
  13. What is the importance of genetic counseling for families affected by Familial Dysautonomia?
    Genetic counseling provides information about inheritance, recurrence risks, and options for future pregnancies.
  14. How does Familial Dysautonomia affect a child's eyes?
    It can cause decreased tear production, corneal ulceration, and optic nerve atrophy.
  15. What is the role of physical therapy in managing Familial Dysautonomia?
    Physical therapy helps improve motor skills, balance, and overall physical function.
  16. How does Familial Dysautonomia affect a child's ability to sweat?
    Many children with Familial Dysautonomia have reduced or absent sweating, contributing to temperature regulation problems.
  17. What nutritional issues are common in children with Familial Dysautonomia?
    Poor feeding, swallowing difficulties, and frequent vomiting can lead to malnutrition and poor growth.
  18. How does Familial Dysautonomia affect a child's sleep patterns?
    Sleep disturbances are common, including sleep apnea and difficulty maintaining normal sleep-wake cycles.
  19. What is the role of occupational therapy in managing Familial Dysautonomia?
    Occupational therapy helps children develop skills for daily living and adapt to their sensory deficits.
  20. How does Familial Dysautonomia affect a child's kidney function?
    It can lead to recurring urinary tract infections and potentially impaired kidney function over time.
  21. What is the importance of regular ophthalmological check-ups for children with Familial Dysautonomia?
    Regular eye exams are crucial to monitor and manage corneal damage due to decreased tear production and reduced blink reflex.
  22. How does Familial Dysautonomia affect a child's skeletal system?
    It can lead to scoliosis, osteoporosis, and increased risk of fractures.
  23. What is the role of speech therapy in managing Familial Dysautonomia?
    Speech therapy helps address speech and swallowing difficulties common in Familial Dysautonomia.
  24. How does Familial Dysautonomia affect a child's cognitive development?
    While intelligence is often normal, learning difficulties and developmental delays are common.
  25. What is the importance of monitoring for autonomic crises in children with Familial Dysautonomia?
    Autonomic crises, characterized by vomiting, hypertension, and tachycardia, can be life-threatening and require prompt management.
  26. How does Familial Dysautonomia affect a child's ability to participate in physical activities?
    Physical activities may be limited due to balance issues, temperature regulation problems, and risk of injury.
  27. What is the role of gastrostomy tubes in managing Familial Dysautonomia?
    Gastrostomy tubes are often used to ensure adequate nutrition and medication administration in children with severe swallowing difficulties.
  28. How does Familial Dysautonomia affect a child's emotional well-being?
    The chronic nature of the condition and its various manifestations can impact emotional well-being, necessitating psychological support.
  29. What is the importance of genetic screening in populations at high risk for Familial Dysautonomia?
    Genetic screening in high-risk populations can identify carriers and allow for informed family planning decisions.
  30. How does Familial Dysautonomia affect a child's oral health?
    Poor oral sensitivity can lead to self-injurious behaviors like biting, necessitating special dental care and monitoring.


Further Reading
Powered by Blogger.